Company profile
Dark Blue Therapeutics
Pioneering the next generation of precision medicines to deliver a portfolio of transformative cancer therapies.
- Industry
- Biotechnology Research
- Employees
- 14
- Headquarters
- Oxford, England
- Founded
- 2020
- LinkedIn followers
- 3,139
- Office locations
- 1
Dark Blue Therapeutics company summary
Dark Blue Therapeutics is a company in the Biotechnology Research industry, headquartered in Oxford, England, founded in 2020. On LinkedIn the company has around 14 employees and 3,139 followers. Its listed specialties include Oncology, Drug discovery, Pharmaceuticals, Precision medicine, Biomarkers.
What technology does Dark Blue Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Dark Blue Therapeutics
Pioneering the next generation of precision medicines to deliver a portfolio of transformative cancer therapies. Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, UK. We have assembled a highly experienced team, whose expertise spans the breadth of drug development from discovery to approval. This expertise has been gained over many years in the industry and draws from biotech, large pharmaceutical companies and investment management. Dark Blue leverages ground-breaking cancer biology insights, from Oxford University, to discover and develop innovative precision medicines that exploit novel vulnerabilities and dependencies. With this deep, proprietary understanding of target biology we match our precision medicines to molecularly defined patient populations to develop transformative, durable drugs that address critical unmet patient needs, delivering medicines that transform the outcomes for cancer patients. We work across a variety of biological mechanisms to identify and pursue only cancer targets that have the highest transformative potential.
Specialties
Where is Dark Blue Therapeutics located?
Dark Blue Therapeutics lists 1 location.
Compare companies similar to Dark Blue Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Dark Blue Therapeutics darkbluetx.com | Biotechnology Research | 14 | 2020 | Oxford, England |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Dark Blue Therapeutics
What does Dark Blue Therapeutics do?
Pioneering the next generation of precision medicines to deliver a portfolio of transformative cancer therapies. Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, UK. We have assembled a highly experienced team, whose expertise spans the breadth of drug development from discovery to approval. This expertise has been gained over many years in the industry and draws from biotech, large pharmaceutical companies and investment management. Dark Blue leverages ground-breaking cancer biology insights, from Oxford University, to discover and develop innovative precision medicines that exploit novel vulnerabilities and dependencies. With this deep, proprietary understanding of target biology we match our precision medicines to molecularly defined patient populations to develop transformative, durable drugs that address critical unmet patient needs, delivering medicines that transform the outcomes for cancer patients. We work across a variety of biological mechanisms to identify and pursue only cancer targets that have the highest transformative potential.
How many employees does Dark Blue Therapeutics have?
Dark Blue Therapeutics has around 14 employees on LinkedIn.
Where is Dark Blue Therapeutics headquartered?
Dark Blue Therapeutics is headquartered in Oxford, England.
When was Dark Blue Therapeutics founded?
Dark Blue Therapeutics was founded in 2020.
Build a lead list from companies like Dark Blue Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.